95 related articles for article (PubMed ID: 28596048)
1. Impact of antigens, adjuvants and strains on sexually dimorphic antibody response to vaccines in mice.
Li X; Guo S; Yang L; Hua L; Li Z; Hao X; Yu Y; Sun W; Wang L
Biologicals; 2017 Jul; 48():47-54. PubMed ID: 28596048
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant effect of Cliptox on the protective immune response induced by an inactivated vaccine against foot and mouth disease virus in mice.
Batista A; Quattrocchi V; Olivera V; Langellotti C; Pappalardo JS; Di Giacomo S; Mongini C; Portuondo D; Zamorano P
Vaccine; 2010 Aug; 28(38):6361-6. PubMed ID: 20637310
[TBL] [Abstract][Full Text] [Related]
3. Use of new adjuvants in an emergency vaccine against foot-and-mouth disease virus: evaluation of conferred immunity.
Quattrocchi V; Bianco V; Fondevila N; Pappalardo S; Sadir A; Zamorano P
Dev Biol (Basel); 2004; 119():481-97. PubMed ID: 15742663
[TBL] [Abstract][Full Text] [Related]
4. Screening and appraisal for immunological adjuvant-active fractions from Platycodon grandiflorum total saponins.
Ouyang K; Chen L; Sun H; Du J; Shi M
Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):126-34. PubMed ID: 21682667
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the antigen presentation activity in foot and mouth disease virus (FMDV) vaccines by two adjuvants: avridine and a water soluble fraction of Mycobacterium sp.
Wigdorovitz A; Zamorano P; Borca MV; Sadir AM
Vaccine; 1998 Oct; 16(17):1627-32. PubMed ID: 9713938
[TBL] [Abstract][Full Text] [Related]
6. Improvement of a commercial foot-and-mouth disease vaccine by supplement of Quil A.
Xiao C; Rajput ZI; Hu S
Vaccine; 2007 Jun; 25(25):4795-800. PubMed ID: 17509735
[TBL] [Abstract][Full Text] [Related]
7. Specific immune response to HBsAg is enhanced by beta-glucan oligosaccharide containing an alpha-(1-->3)-linked bond and biased towards M2/Th2.
Dong SF; Chen JM; Zhang W; Sun SH; Wang J; Gu JX; Boraschi D; Qu D
Int Immunopharmacol; 2007 Jun; 7(6):725-33. PubMed ID: 17466906
[TBL] [Abstract][Full Text] [Related]
8. [Molecular design and immunogenicity of a multiple-epitope foot-and-mouth disease virus antigen, adjuvants, and DNA vaccination].
Ma M; Jin N; Yin G; Lu H; Li C; Jin K; Qu Z
Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):514-9. PubMed ID: 19637624
[TBL] [Abstract][Full Text] [Related]
9. Additive effects of CpG ODN and R-848 as adjuvants on augmenting immune responses to HBsAg vaccination.
Ma R; Du JL; Huang J; Wu CY
Biochem Biophys Res Commun; 2007 Sep; 361(2):537-42. PubMed ID: 17662694
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J
Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860
[TBL] [Abstract][Full Text] [Related]
11. A Recombinant Adenovirus Expressing P12A and 3C Protein of the Type O Foot-and-Mouth Disease Virus Stimulates Systemic and Mucosal Immune Responses in Mice.
Xie Y; Gao P; Li Z
Biomed Res Int; 2016; 2016():7849203. PubMed ID: 27478836
[TBL] [Abstract][Full Text] [Related]
12. Florfenicol impairs the immune responses to vaccination against foot-and-mouth disease in mice.
Guan S; Lu J; Shen X; Qian W; Liu J; Deng X
Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):609-13. PubMed ID: 21428714
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
[TBL] [Abstract][Full Text] [Related]
14. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
[TBL] [Abstract][Full Text] [Related]
15. No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.
Tekleghiorghis T; Weerdmeester K; van Hemert-Kluitenberg F; Moormann RJ; Dekker A
Vaccine; 2014 Sep; 32(41):5330-6. PubMed ID: 25092634
[TBL] [Abstract][Full Text] [Related]
16. Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice.
Song X; Bao S; Wu L; Hu S
Vaccine; 2009 Jan; 27(1):51-5. PubMed ID: 18973783
[TBL] [Abstract][Full Text] [Related]
17. Improved neutralising antibody response against foot-and-mouth-disease virus in mice inoculated with a multi-epitope peptide vaccine using polyinosinic and poly-cytidylic acid as an adjuvant.
Cao Y; Lu Z; Li P; Sun P; Fu Y; Bai X; Bao H; Chen Y; Li D; Liu Z
J Virol Methods; 2012 Oct; 185(1):124-8. PubMed ID: 22766183
[TBL] [Abstract][Full Text] [Related]
18. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant effect enhancement of porcine interleukin-2 packaged into solid lipid nanoparticles.
Chen G; Zeng S; Jia H; He X; Fang Y; Jing Z; Cai X
Res Vet Sci; 2014 Feb; 96(1):62-8. PubMed ID: 24374120
[TBL] [Abstract][Full Text] [Related]
20. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
